Study

Bioartificial kidney under study at MCG

Whether a bioartificial kidney containing billions of donor kidney cells will help intensive care patients with kidney failure survive is under study at the Medical College of Georgia. MCG Medical Center has joined a study taking place in intensive care units across the country to evaluate the efficacy of the renal assist device, says Dr. Harold M. Szerlip, MCG nephrologist specializing i...

Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down

For patients with high-risk breast cancer treated with radical mastectomy and adjuvant chemotherapy, the addition of radiation therapy leads to better survival outcomes with few long-term toxic effects, according to a 20-year follow-up of a randomized trial, which appears in the January 19 issue of the Journal of the National Cancer Institute. The British Columbia randomized radiation the...

W.M. Keck Foundation funds study of friendly microbes

You could say that the Human Genome Project missed 99 percent of the genes in the adult body. That's because it didn't sequence genes belonging to the vast communities of bacteria that normally live on and in us. Now a $1.45 million grant from the W.M. Keck Foundation to researchers at the School of Medicine will help fill this gap by funding a study to develop new approaches for isolatin...

Yellowstone microbes fueled by hydrogen, according to U. of Colorado study

Microbes living in the brilliantly coloredhot springs of Yellowstone National Park use primarily hydrogen forfuel, a discovery University of Colorado at Boulder researchers saybodes well for life in extreme environments on other planets and couldadd to understanding of bacteria inside the human body.A team of CU-Boulder biologists led by Professor Norman Pace, one ofthe world's leading expe...

Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs

Physicians at Emory University School ofMedicine are conducting a clinical trial using stem cells generatedwithin the bone marrow to grow new blood vessels that could improvecirculation in patients with blockages in the arteries of their legs --a condition called (PVD). Individuals with PVD...

More>>

Study at Biology Products

No data found

Search Study biology products at Google

Search Study biology products at Yahoo

Search Study biology products at Msn

Study at Biology Technology

Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling

Danny Q. Hoang Michael Browning Xinping Yang PeterPingerelli Stratagene Cloning Systems, Inc. Stratagene introduces affinity purified antibodies for NMDA receptorsubunits that are useful for studying expression of the NR2A, NR2B and NR2Csubunit proteins...

Optimizing Transfection Conditions for Studying Signal Transduction Pathways

Optimizing Transfection Conditions for Studying Signal TransductionPathways in vivo reporting systems Stratagene Stratagenes PathDetect <font face="S...

Enzyme Immunoassay for Studying Intracellular Levels of cAMP

Sensitive, nonradioactive cyclic-AMP detection kit and adenylate cyclase(AC) toxin Stratagene Cloning Systems, Inc. American Qualex Stratagenes EIA cAMP Kit is a highly sensitive and specificantibody-based assay kit for no...

RT-PCR Primers for the Study of Apoptosis

Wei-ping Yang Danny Hoang Douglas McKenzie PeterPingerelli Stratagene The apoptotic response is a complex biological process that requires theregulation of a variety of genes that interact with and respond to intracellularand extracellular stimuli. Stratagene is introducing RT-PCR primer<sup...

A Comparison Study of Lipid Tranfection Reagents in A549, NIH 3T3 and COS-7 Cell Lines

Genetic Applications LLC transfection reagent canbe used for simple and reproducible delivery of foreign DNA into mammaliancells. In this study, we used varying amounts of LipoTAXI transf...

More>>

Study at Medicine News

A new study surpasses Gene Therapy Hurdle

According to researchers at Hopkins University, they have found a way to use blood stem cells to make genetic changes in the immune system, surpassing an obstacle to certain forms of gene therapy. The implications, biologist Lingho Chengh range from improving the body's immune response to developing cancer vaccines to reducing the danger of rejecting transplanted organs. Blood stem cells form th...

Tomato Sauce reduces Cancer Risk- Study

According to a study, men who eat up tomato products more than twice a week can obviously reduce their chances of contracting prostate cancer. Consuming cooked tomatoes was particularly beneficial, according to the study, which showed that regularly eating tomato sauce, ketchup and other tomato-based foods lowered the prostate cancer risk by as much as 30 percent.// Dr. Edward Giovannu...

A question on study of Adult Stem Cell

Two studies may form a tiresome feeling over visions of adult stem cells as a less honestly questionable but nearly equally versatile alternative to embryonic stem cells, whose ability to sprout different cell types has spawned debate between those who think such research destroys a life and those who say it has life-saving potential. The new findings challenge the notion adult stem cells taken f...

Study on obesity and heart failure

Obesity is the most common risk factors for most of the prevailing ailments. A new study finds obesity is an important risk factor for heart failure in both men and women. Till now, doctors identifies extreme obesity as a risk factor for heart failure.// However, it has been unclear if lesser degrees of obesity also pose a risk. Researchers from Boston University School of Medicine investigated t...

Revealing Study Results May Do More Harm Than Good

There has been clamor recently to disclose the results of study findings with participants after the completion of the study. However, a commentary published in the April 1, 2006 issue of CANCER,// a peer-reviewed journal of the American Cancer Society, says that such disclosures may actually do more harm than good as they cause unnecessary psychological stress to patients. Maurie Markm...

More>>

Study at Medicine Products

Chromosome Analysis, High Resolution (Prometaphase Study)

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Study at Medicine Technology

Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer

NEW YORK, July 12, 2007 /PRNewswire-FirstCall/ -- ImCloneSystems Incorporated and Bristol-Myers Squibb Company todayannounced results from an open-label Phase III study of ERBITUX(R)(Cetuximab) plus a taxane and carboplatin in the first-linetreatment for metastatic non-small cell lung cancer (NSCLC). Thestudy did not meet its primary endpoint of progression-freesurvival (PFS) as assessed...

Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs

IRVING, Texas--(BUSINESS WIRE)--Jul 11, 2007 - The Journal of theAmerican Society of Clinical Oncology has published the earlyresults of a clinical study conducted by Dr. Siu-Fun Wong, and hercolleagues, which concluded that the topical gel, Regenecare(R),caused a statistically significant reduction in the pain anditching of a rash that results from the use of anti-cancer drugsknown as EGFR...

Cell Therapeutics, Inc. Management to Discuss Today's Announcement of Interim Pixantrone Study Results

SEATTLE, July 11, 2007 /PRNewswire-FirstCall/ -- On Wednesday,July 11, 2007, at 1:30 p.m. Pacific/4:30 p.m. Eastern/10:30 p.m.Central European Time members of Cell Therapeutics, Inc.'s (CTI)management team will host a conference call to discuss today'sannouncement of the interim results of its phase II/III RAPID trialcomparing CHOP-R to CPOP-R, in which pixantrone is substituted fordoxor...

Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis

LEVERKUSEN, Germany - Biofrontera AG (DSE: B8F) announces todaythat it has received very positive results in the dose finding partof its phase IIb/III clinical trial started in autumn 2006. BF-200ALA, a gel that combines the active substance 5-aminolevulinic acid(ALA) with the nanoemulsion BF-200, was strongly and significantlysuperior to placebo in the treatment of actinic keratosis. BF-...

Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures

EAST HANOVER, N.J.--(BUSINESS WIRE)--Jul 11, 2007 - Since the May2007 release of a New England Journal of Medicine (NEJM) reportthat Avandia users are 43 percent more likely to suffer a heartattack and 67 percent more likely to die of cardiovascular causesthan non-users of Avandia, it is no surprise that physicians intendto switch many type 2 diabetes patients from Avandia to therapiesbelie...

More>>